Stock TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
42.19 USD -0.12% Intraday chart for Taro Pharmaceutical Industries Ltd. +0.14% +0.98%
Jan. 25 Taro Pharmaceutical Industries Fiscal Q3 Net Income, Net Sales Rise; Shares Climb After Hours MT
Jan. 25 Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Business Summary

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Number of employees: 1,554

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
561 100.0 % 573 100.0 % +2.07%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
63.4 %
377 67.1 % 363 63.4 % -3.61%
Canada
23.8 %
130 23.2 % 136 23.8 % +4.75%
Israel
8.1 %
48 8.5 % 46 8.1 % -3.70%
Other
4.8 %
7 1.2 % 28 4.8 % +311.17%

Managers

Managers TitleAgeSince
Uday Vijaykumar Baldota CEO
 Chief Executive Officer 54 16-11-30
William Coote DFI
 Director of Finance/CFO 69 07-12-31
Richard Glaze CTO
 Chief Tech/Sci/R&D Officer 58 -
Hagai Reingold COO
 Chief Operating Officer - 01-12-31
Avi Avramoff CTO
 Chief Tech/Sci/R&D Officer 59 11-09-30
James Kedrowski BRD
 Director/Board Member 72 10-09-30
David Kinzelberg AUD
 Comptroller/Controller/Auditor - -
Erik Zwicker LAW
 General Counsel 44 20-04-12
Abhay Gandhi PRN
 Corporate Officer/Principal 59 16-11-30
Michele Visosky HRO
 Human Resources Officer 58 03-12-31

Members of the board

Members of the board TitleAgeSince
Robert Stein BRD
 Director/Board Member 73 20-01-31
Dilip Shantilal Shanghvi CHM
 Chairman 68 10-09-21
Sudhir Vrundavandas Valia BRD
 Director/Board Member 67 10-08-31
Oded Sarig BRD
 Director/Board Member 68 23-06-26
Uday Vijaykumar Baldota CEO
 Chief Executive Officer 54 16-11-30
James Kedrowski BRD
 Director/Board Member 72 10-09-30
Linda Ben Shoshan BRD
 Director/Board Member 58 16-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 3,719 2,600 0 0 17.92 %
Stock B 1 45,116,262 8,086,818 ( 17.92 %) 7,531,631 ( 16.69 %)

Shareholders

NameEquities%Valuation
SUN PHARMACEUTICAL INDUSTRIES LTD.
78.48 %
29,497,813 78.48 % 1 249 M $
Krensavage Asset Management LLC
1.720 %
646,453 1.720 % 27 M $
BlackRock Advisors LLC
1.564 %
587,969 1.564 % 25 M $
Renaissance Technologies LLC
1.542 %
579,400 1.542 % 25 M $
Dimensional Fund Advisors LP
1.452 %
545,682 1.452 % 23 M $
Brandes Investment Partners LP
1.266 %
475,741 1.266 % 20 M $
Ameriprise Financial Services LLC
0.8174 %
307,225 0.8174 % 13 M $
Eversept Partners LP
0.6811 %
255,988 0.6811 % 11 M $
Invesco Advisers, Inc.
0.6292 %
236,486 0.6292 % 10 M $
Murchinson Ltd.
0.4464 %
167,782 0.4464 % 7 M $
NameEquities%Valuation
SUN PHARMACEUTICAL INDUSTRIES LTD.
100.00 %
2,600 100.00 % 1 M $

Company contact information

Taro Pharmaceutical Industries Ltd.

14 Hakitor Street

2624761, Haifa Bay

+972 4 847 5700

http://www.taro.com
address Taro Pharmaceutical Industries Ltd.(TARO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
42.19 USD
Average target price
43 USD
Spread / Average Target
+1.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TARO PHARMACEUTICAL INDUSTRIES LTD. Stock Taro Pharmaceutical Industries Ltd.
+0.98% 1.59B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 211B
NOVARTIS AG Stock Novartis AG
-0.41% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TARO Stock
  4. Company Taro Pharmaceutical Industries Ltd.